Amol Shete

729 total citations
39 papers, 543 citations indexed

About

Amol Shete is a scholar working on Pharmaceutical Science, Materials Chemistry and Analytical Chemistry. According to data from OpenAlex, Amol Shete has authored 39 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 11 papers in Materials Chemistry and 8 papers in Analytical Chemistry. Recurrent topics in Amol Shete's work include Drug Solubulity and Delivery Systems (16 papers), Crystallization and Solubility Studies (10 papers) and Analytical Methods in Pharmaceuticals (8 papers). Amol Shete is often cited by papers focused on Drug Solubulity and Delivery Systems (16 papers), Crystallization and Solubility Studies (10 papers) and Analytical Methods in Pharmaceuticals (8 papers). Amol Shete collaborates with scholars based in India, United States and Malaysia. Amol Shete's co-authors include Adhikrao Yadav, Sfurti Sakhare, P. V. Kulkarni, Shivajirao Kadam, Vivek Patil, Chitra Khanwelkar, Sameer Nadaf, Niraj Kumar Jha, Arehalli S. Manjappa and Popat Kumbhar and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Amol Shete

33 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amol Shete India 11 250 210 194 98 88 39 543
Sanjay S. Pekamwar India 12 163 0.7× 133 0.6× 134 0.7× 90 0.9× 97 1.1× 37 551
Sameer R. Modi India 14 323 1.3× 166 0.8× 297 1.5× 54 0.6× 68 0.8× 17 580
Indumathi Sathisaran India 10 266 1.1× 222 1.1× 105 0.5× 88 0.9× 58 0.7× 13 480
Inna Miroshnyk Finland 15 411 1.6× 256 1.2× 238 1.2× 101 1.0× 110 1.3× 21 732
Chad Dalton Canada 11 226 0.9× 108 0.5× 232 1.2× 69 0.7× 84 1.0× 14 529
Ilma Nugrahani Indonesia 13 253 1.0× 205 1.0× 85 0.4× 102 1.0× 95 1.1× 63 501
Weili Heng China 14 240 1.0× 65 0.3× 305 1.6× 68 0.7× 72 0.8× 32 572
Mohammad Amin Mohammad United Kingdom 11 455 1.8× 196 0.9× 218 1.1× 150 1.5× 64 0.7× 19 771
Waree Limwikrant Japan 16 213 0.9× 76 0.4× 254 1.3× 101 1.0× 131 1.5× 41 651
Khouloud A. Alkhamis Jordan 13 137 0.5× 61 0.3× 159 0.8× 89 0.9× 72 0.8× 28 455

Countries citing papers authored by Amol Shete

Since Specialization
Citations

This map shows the geographic impact of Amol Shete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol Shete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol Shete more than expected).

Fields of papers citing papers by Amol Shete

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol Shete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol Shete. The network helps show where Amol Shete may publish in the future.

Co-authorship network of co-authors of Amol Shete

This figure shows the co-authorship network connecting the top 25 collaborators of Amol Shete. A scholar is included among the top collaborators of Amol Shete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol Shete. Amol Shete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shete, Amol, et al.. (2025). Design and Development of Dasatinib Nanoemulsions for Ocular Delivery: In vitro Characterization, Biocompatibility, and Ex vivo Ocular Irritation Study. International Journal of Pharmaceutics. 675. 125504–125504. 1 indexed citations
2.
Kumbhar, Popat, Sukriti Vishwas, Sameer Nadaf, et al.. (2025). Expanding arsenal against colorectal cancer using guar gum-based nanocarriers: A review. International Journal of Biological Macromolecules. 320(Pt 1). 145765–145765. 1 indexed citations
3.
Shete, Amol, et al.. (2025). CDSCO alerts: A retrospective dosage form - Wise analysis of quality control alerts issued to pharmaceutical companies from 2018 to 2023. Regulatory Toxicology and Pharmacology. 156. 105775–105775.
4.
Shete, Amol, et al.. (2024). Current Perspectives on Development and Applications of Cocrystals in the Pharmaceutical and Medical Domain. Cureus. 16(9). e70328–e70328. 2 indexed citations
5.
Khanwelkar, Chitra, et al.. (2024). IN SILICO EXPLORATION OF BERBERINE AS A POTENTIAL WOUND HEALING AGENT VIA NETWORK PHARMACOLOGY, MOLECULAR DOCKING, AND MOLECULAR DYNAMICS SIMULATION. International Journal of Applied Pharmaceutics. 188–194. 11 indexed citations
6.
Khanwelkar, Chitra, et al.. (2024). 3D Printing in Wound Healing: Innovations, Applications, and Future Directions. Cureus. 16(12). e75331–e75331. 6 indexed citations
7.
9.
Shete, Amol, et al.. (2022). Screening of Aceclofenac for Cocrystallization with Nicotinamide: Theoretical and Practical Perspective. Indian Journal of Pharmaceutical Sciences. 84(6).
10.
Kumbhar, Popat, Sameer Nadaf, Arehalli S. Manjappa, et al.. (2022). D-ɑ-tocopheryl polyethylene glycol succinate: A review of multifarious applications in nanomedicines. OpenNano. 6. 100036–100036. 35 indexed citations
11.
Shete, Amol, et al.. (2018). Studies on Release Performance of Proniosmes and its Tablets of BCS Class II Drug Simvastatin. Der pharmacia lettre. 10(4). 45–56. 1 indexed citations
12.
Shete, Amol, et al.. (2015). Enhancement of dissolution rate of indomethacin by kollicoat IR based solid dispersions. Der pharmacia lettre. 7(8). 64–73. 5 indexed citations
13.
Shete, Amol, et al.. (2015). Formulation and solid state characterization of nicotinamide-based co-crystals of fenofibrate. Indian Journal of Pharmaceutical Sciences. 77(3). 328–328. 43 indexed citations
14.
Shete, Amol, et al.. (2013). SIMULTANEOUS ESTIMATION OF DULOXETINE HYDROCHLORIDE AND METHYLCOBALAMIN BY UV SPECTROSCOPIC METHOD. International Journal of Pharmacy. 3(10). 734–740. 1 indexed citations
15.
Patil, Supriya A., et al.. (2013). Design, Development and In Vitro Characterization of Self Emulsifying Drug Delivery System for Irbesartan. Iranian journal of pharmaceutical sciences. 9(2). 67–80. 4 indexed citations
16.
Shete, Amol, et al.. (2012). Enhancement of Dissolution Rate of Irbesartan by Chitosan based Crystal Engineering Technique. Indian Journal of Pharmaceutical Education and Research. 46(4). 8 indexed citations
17.
Shete, Amol, et al.. (2012). Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form. Drug Development and Industrial Pharmacy. 39(5). 716–723. 10 indexed citations
18.
Shete, Amol, et al.. (2012). Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol. DARU Journal of Pharmaceutical Sciences. 20(1). 93–93. 21 indexed citations
19.
Yadav, Adhikrao, et al.. (2010). Formulation and Evaluation of Orodispersible Liquisolid Compacts of Aceclofenac. Indian Journal of Pharmaceutical Education and Research. 44(3). 19 indexed citations
20.
Yadav, Adhikrao, et al.. (2009). Co-crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian Journal of Pharmaceutical Sciences. 71(4). 359–359. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026